Characterization of the Expression and Immunogenicity of Poliovirus Replicons that Encode Simian Immunodeficiency Virus SIVmac239 Gag or Envelope SU Proteins

No abstract is available for this paper.

• Publication year

  1997

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  1997-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/aid.1997.13.53PMID 8989427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes

  2005cited by this paper
• Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag

  1996cited by this paper
• Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14.

  1996cited by this paper
• Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120

  1995cited by this paper
• Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans

  1995cited by this paper
• Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.

  1995influential reference
• Infection and Apoptotic Cell Death of CD4+ T Cells during an Immune Response to HIV-1-Pulsed Dendritic Cells

  1994cited by this paper
• New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection.

  1994influential reference
• Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection

  1993cited by this paper
• Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans

  1993cited by this paper
• Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication.

  1993cited by this paper
• Folding and assembly of viral membrane proteins.

  1993cited by this paper
• Protein folding in the cell

  1992cited by this paper
• The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles

  1992cited by this paper
• Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons

  1991cited by this paper
• Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac

  1991cited by this paper
• Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures

  1991cited by this paper
• The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.

  1990cited by this paper
• Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

  1990cited by this paper
• Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles

  1990cited by this paper
• Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.

  1990cited by this paper
• The Complete Nucleotide Sequence of a Pathogenic Molecular Clone of Simian Immunodeficiency Virus

  1990cited by this paper
• Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing

  1989cited by this paper
• Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

  1989cited by this paper
• Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

  1989cited by this paper
• Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.

  1989cited by this paper
• Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor.

  1988cited by this paper
• Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro.

  1988cited by this paper
• Construction and characterization of poliovirus subgenomic replicons

  1988cited by this paper
• Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins

  1987cited by this paper
• A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

  1986cited by this paper
• Systematic nomenclature of picornavirus proteins

  1984cited by this paper
• Cloned poliovirus complementary DNA is infectious in mammalian cells.

  1981cited by this paper
• Primary structure, gene organization and polypeptide expression of poliovirus RNA

  1981cited by this paper

• 2 The Primary Viruses of Myocarditis

  2019cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• Humoral immune responses against novel recombinant replication-competent poxvirus candidate vaccines expressing full length and chimeric lyssavirus glycoprotein genes

  2011cites this paper
• Kunjin replicon-based simian immunodeficiency virus gag vaccines

  2008cites this paper
• Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.

  2006cites this paper
• Chapter 10 – Simian Retroviruses

  2004cites this paper
• The Primary Viruses of Myocarditis

  2003cites this paper
• HIV vaccine development: lessons from the past and promise for the future.

  2003cites this paper
• HIV Vaccines Design and Development

  2002cites this paper
• Expression of a Membrane-Anchored Glycoprotein, the Influenza Virus Hemagglutinin, by Dicistronic Replicons Derived from the Poliovirus Genome

  2002cites this paper
• Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.

  2001cites this paper
• Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

  2000cites this paper
• A three-year survey of nosocomial and community-acquired infections, antibiotic treatment and re-hospitalization in a Norwegian health region.

  2000cites this paper
• New approaches to antigen delivery.

  2000cites this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cites this paper
• Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.

  1999cites this paper
• Designing a Vaccine Against HIV

  1999cites this paper
• New viral vectors for HIV vaccine delivery.

  1998cites this paper
• Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase.

  1998cites this paper
• Construction and Characterization of Encapsidated Poliovirus Replicons That Express Biologically Active Murine Interleukin-2

  1998cites this paper
• Mini-Review: New Viral Vectors for HIV Vaccine Delivery

  1998cites this paper
• Recombinant viruses as vaccines and immunological tools.

  1997cites this paper
• Mini-Review New Viral Vectors for HIV Vaccine Delivery

  year unknowncites this paper